Skip to main content
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc.

$1.14 +0.04 (+3.64%) At close · Jul 21
Market Cap
$275.47M
Shares
249.30M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-30 14,119 $1.35 $19,061
2026-06-25 154 $1.26 $194
2026-06-24 1,818 $1.25 $2,273
2026-06-23 9 $1.26 $11
2026-06-22 9 $1.21 $11
2026-06-15 49 $1.27 $62
2026-06-05 13,962 $1.21 $16,894
2026-06-03 475 $1.21 $575
2026-06-02 475 $1.26 $599
2026-06-01 67 $1.33 $89
2026-05-27 3,884 $1.29 $5,010
2026-05-20 971 $1.20 $1,165
2026-05-15 481 $1.31 $630
2026-05-14 481 $1.28 $616
2026-05-12 782 $1.31 $1,024
2026-05-11 49 $1.37 $67
2026-05-08 30,963 $1.37 $42,419
2026-05-06 86 $1.46 $126
2026-04-30 294 $1.46 $429
2026-04-29 1,484 $1.56 $2,315
2026-04-24 1,587 $1.56 $2,476
2026-04-23 1,587 $1.63 $2,587
Showing 1–22 of 22 settlements
Key facts CIK 876343 CUSIP 53566P109 13F (30d) 9 filings 9 filers Visit website Investor relations